Skip to main content
logo
Zydus Lifesciences Limited (BOM:532321)
India flag India · Delayed Price · Currency is INR
1,150.50
-9.35 (-0.81%)
At close: Jul 10, 2026

Zydus Lifesciences Revenue

In the fiscal year ending March 31, 2026, Zydus Lifesciences had annual revenue of 271.48B INR with 16.81% growth. Zydus Lifesciences had revenue of 75.87B in the quarter ending March 31, 2026, with 16.22% growth.

Revenue
271.48B
Revenue Growth
+16.81%
P/S Ratio
4.16
Revenue / Employee
9.06M
Employees
27,917
Market Cap
1.13T

Revenue Chart

Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Mar 31, 2026271.48B39.07B16.81%
Mar 31, 2025232.42B36.94B18.90%
Mar 31, 2024195.47B23.10B13.40%
Mar 31, 2023172.37B21.28B14.08%
Mar 31, 2022151.10B7.06B4.90%
Mar 31, 2021 Pro Pro Pro
Mar 31, 2020 Pro Pro Pro
Mar 31, 2019 Pro Pro Pro
Mar 31, 2018 Pro Pro Pro
Mar 31, 2017 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Dr. Reddy's Laboratories335.93B
Lupin279.58B
Torrent Pharmaceuticals139.80B
Jubilant Pharmova82.80B
Abbott India69.29B
Granules India53.66B
J. B. Chemicals & Pharmaceuticals41.48B
GlaxoSmithKline Pharmaceuticals38.22B
Revenue Rankings

Zydus Lifesciences News

More News